JW Asset Management LLC Sells 100,000 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

JW Asset Management LLC lessened its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 3.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,092,485 shares of the company's stock after selling 100,000 shares during the quarter. Establishment Labs comprises 67.7% of JW Asset Management LLC's holdings, making the stock its largest position. JW Asset Management LLC owned 11.04% of Establishment Labs worth $142,471,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in ESTA. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of Establishment Labs by 1.8% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company's stock valued at $1,525,000 after purchasing an additional 632 shares in the last quarter. R Squared Ltd acquired a new stake in shares of Establishment Labs in the 4th quarter worth $36,000. Verition Fund Management LLC raised its holdings in shares of Establishment Labs by 22.8% during the 3rd quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock worth $407,000 after acquiring an additional 1,746 shares during the period. Handelsbanken Fonder AB boosted its position in shares of Establishment Labs by 32.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after acquiring an additional 2,000 shares during the last quarter. Finally, HighTower Advisors LLC grew its holdings in shares of Establishment Labs by 32.5% in the third quarter. HighTower Advisors LLC now owns 10,311 shares of the company's stock valued at $446,000 after purchasing an additional 2,529 shares during the period. 72.91% of the stock is owned by institutional investors and hedge funds.

Remove Ads

Wall Street Analysts Forecast Growth

Separately, Stephens reaffirmed an "overweight" rating and set a $52.00 target price on shares of Establishment Labs in a research note on Thursday, March 6th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $57.40.

Establishment Labs Trading Down 8.5 %

Shares of NASDAQ:ESTA traded down $3.23 during midday trading on Thursday, reaching $34.82. 438,671 shares of the company's stock were exchanged, compared to its average volume of 418,556. The stock has a market cap of $1.00 billion, a price-to-earnings ratio of -13.50 and a beta of 0.95. Establishment Labs Holdings Inc. has a fifty-two week low of $28.16 and a fifty-two week high of $60.12. The firm's 50 day simple moving average is $36.62 and its two-hundred day simple moving average is $41.15. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The company had revenue of $44.51 million for the quarter, compared to analyst estimates of $44.45 million. As a group, sell-side analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.